Article
Differential gene expression profiling of CD34+ CD133+ umbilical cord blood hematopoietic stem progenitor cells.
Stem cells and development - 1 Apr 2005
He Xianghui, Gonzalez Veronica, Tsang Amy, Thompson Jennifer, Tsang Tom C, Harris David T
Abstract excerpt
Umbilical cord blood (CB)-derived primitive hematopoietic stem progenitor cells (HSPC) are a promising source for stem cell-based gene therapy due to the reduced incidence and severity of graftversus- host disease (GVHD) after human leukocyte antigen (HLA)-disparate CB transplantation. Cell-surface markers such as CD34 and CD133 have been used in combination to enrich primitive HSPC for research and clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
